跳至主要内容
临床试验/NCT04309994
NCT04309994已完成不适用

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 307 人开始时间: 2010年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
307
试验地点
1
主要终点
myocardial damage

研究概览

简要总结

The goal of this study is to compare the two cardioplegia solutions (blood cardioplegia by means of MPS ® vs. Cardioplexol ®) regarding perioperative outcome and with special attention to cardiac markers in patients with a recent heart attack.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who underwent a CABG using MPS® or Cardioplexol ®
  • Heart attack less than 7 days before surgery

排除标准

  • use of other cardioplegia solution than Cardioplexol ® or MPS®
  • other inventions than CABG
  • explicit will of the patient that his data may not be used
  • denied general consent

结局指标

主要结局

myocardial damage

时间窗: patients with that received a coronary artery bypass grafting and that were treated (for approximately 15 days) at the University Hospital between February 2010 and January 2020 (data taken perioperative during hospital stay for CABG)

Analyse cardiac biomarkers as indicators for myocardial damage: high sensitive troponin (Ths-TrT, ng/mL), creatine kinase (CK, in ng/mL) and creatine kinase-MB isoenzyme (CK-MB, in ng/mL)

次要结局

  • 30 days Mortality(30 days after CABG)
  • length of stay in the intensive care unit(perioperative during hospital stay for CABG (for approximately 15 days))
  • Number of participants with bleedings(perioperative during hospital stay for CABG (for approximately 15 days))
  • Number of participants with postoperative arrhythmia(perioperative during hospital stay for CABG (for approximately 15 days))

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Combined Use of a Novel Cardioplegic Formula With... | 临床试验